The patent EP3612550 was granted to Glaxosmithkline on Jun 18, 2025. The application was originally filed on Apr 18, 2018.

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents